Perrigo | PRGO - Loan Capital


Perrigo reported $3.28B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
Abbott USD 29.64B 19.74B Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Dr.Reddys Laboratories INR 12.2B 595M Mar/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
J&J USD 37.34B 183M Jun/2026
Merck USD 51.08B 4.41B Jun/2026
Nestle CHF 46.5B 254M Jun/2026
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.28B 337.7M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 2.02B 1.01B Jun/2026
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi EUR 14.65B 806M Jun/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026
Zoetis USD 9.05B 3M Jun/2026